We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Laboratory Medicine and Nosocomial infections: Solutions in the Pipeline

By LabMedica International staff writers
Posted on 25 Feb 2010
On the horizon is technology from the molecular diagnostic company Great Basin Scientific (Salt Lake City, UT, USA). More...
The company's technology is designed to improve the traditional methods of diagnostic testing of hospital-acquired infections, such as methicillin-resistant Staphylococcus aureus (MRSA), allowing test results to come back in less than an hour versus the traditional one- to two-day waiting period.

Great Basin Scientific's silicon chip-based technology is simple, cost-effective, and better than the highly complex, traditional polymerase chain reaction (PCR) method that requires the skills of highly trained technicians and sometimes even multiple rooms to avoid cross contamination of tests. The company's sensitive, easy-to-use integrated cartridge system, which can be performed in a clinical laboratory improved amendments (CLIA)-rated moderately complex or waived laboratory, will give health care providers and their patients the benefit of point-of-care test results within a 20- to 60-minute time frame at costs much lower than current molecular solutions.

In the past two decades, one of the most important discoveries to come out of the microbiology world is the fact that bacteria can communicate. They are able converse on a level where they can induce each other to switch on dormant genes that then have the capacity to do harm.

The superbug methicillin-resistant Staphylococcus aureus (MRSA) is part of this phenomenon, called "quorum sensing.” Quorum sensing is the ability of bacteria to communicate and coordinate behavior using signaling molecules called autoinducers. Autoinducers are continuously produced by bacteria but when their concentration reaches a certain threshold--that is, when the bacteria producing it have a quorum--they switch on transcription genes within the bacteria's DNA telling it to do two things: to produce more autoinducer and, crucially, to change behavior.

Once a biofilm is established it is very difficult to get rid of as can be witnessed by the ubiquity of dental plaque and dogged resistance of MRSA to treatment. There have been attempts to solve this problem with some promising results. For example, Jong-Chul Park at the Cellbiocontrol Laboratory, Department of Medical Engineering, Yonsei University College of Medicine (Seoul, Korea) and colleagues reported that they were able to rapidly remove biofilms and planktonic bacteria on glass by using microwave-induced argon plasma at atmospheric pressure. Their work was published on November 28, 2009 in the New Journal of Physics.

Related Links:

Great Basin Scientific
Yonsei University College of Medicine




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.